ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1511

Real-Life Performance of the ASAS Health Index in Routine Care of Patients with Spondyloarthritis

Uta Kiltz, Thomas Wiatr, Xenofon Baraliakos, Kirill Fedorov and Jürgen Braun, Rheumazentrum Ruhrgebiet, Herne, Germany

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Clinical practice, Outcome measures, quality of life and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The ASAS Health Index (ASAS HI) have been developed to measure health and impairment in functioning in patients with spondyloarthritis (SpA). Its measurement properties have already been evaluated in a cohort study. So far, its association with structural damage has not been examined. The purpose is to investigate the relationship between clincial data, function and health as assessed by the ASAS HI and to investigate the influence of structural spinal damage in patients with axial SpA (axSpA) on the ASAS HI.

Methods: Patients fullfilling ASAS classification criteria for axial SpA (axSpA) were recruited prospectively. Information was collected on clinical assessments (ASAS HI, NRS pain, BASDAI, ASDAS, BASFI, BASMI), laboratory parameters and spinal x-rays. Imaging were scored using mSASSS by two independent readers. The relationship between ASAS HI and other health outcomes was evaluated by Spearman correlation.

Results: A total of 150 patients (57 nr-axSpA and 93 AS patients) were included: 68.7% male, mean (SD) age 46.4 (14.1), symptom duration 18.7 (13.5) and diagnosis since 11.4 (11.8) years, and HLA-B27 positive in 82.0%. Values of clinical assessments were ASAS HI 7.4 (4.1), BASDAI 4.7 (2.3), ASDAS 2.7 (1.1), BASMI 3.3 (1.8), pain 5.7 (2.7), and BASFI 4.7 (2.6). An elevated CRP level was found in 34.8% of the patients. Radiographs of the sacroiliac (SI) joint and the spine were available in 138 patients, 38.0% of which had syndesmophytes and 7.5% a bamboo spine. The median (IQR) mSASSS value was 4.3 (IQR 1.0-22.1) in AS und 0.2 (IQR 0.0-1.4) in nr-axSpA patients. Patients received a treatment with NSAIDs (62.7%), DMARDs (20.9%) and/or biologics (49.4%). Significant correlation of ASAS HI was noted for BASMI (0.5), BASDAI (0.7), ASDAS (0.5) and BASFI (0.8).No correlations were found for ASAS HI and any of the results for radiographic damage (mSASSS 0.2, syndesmophytes 0.01, bamboo spine 0.2) and CRP level (0.07). Startifying patient population by symptom duration (cut-off 3 years) does not change the results.

Conclusion: Measures of function and spinal mobility correlate well with the ASAS HI in patients with SpA. Probably due to relatively low mSASSS scores at baseline, the influence of structural changes as measured by mSASSS on the ASAS HI was rather limited in this study. Further study in more severely affected patients is needed to study the association of physical activity, spinal mobility, function and radiographic damage.


Disclosure: U. Kiltz, None; T. Wiatr, None; X. Baraliakos, None; K. Fedorov, None; J. Braun, None.

To cite this abstract in AMA style:

Kiltz U, Wiatr T, Baraliakos X, Fedorov K, Braun J. Real-Life Performance of the ASAS Health Index in Routine Care of Patients with Spondyloarthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/real-life-performance-of-the-asas-health-index-in-routine-care-of-patients-with-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/real-life-performance-of-the-asas-health-index-in-routine-care-of-patients-with-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology